Collegium Pharmaceutical, Inc. (Nasdaq: COLL) has entered into an accelerated share repurchase (ASR) agreement with Jefferies LLC to repurchase $50 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE